So today I actually got to go to the lab and do some research along two MDs and one undergraduate from Duke. Today was mainly an observing day to get a feel for the lab and all of the protocols. I observed the two MD students conduct research while I sat with the undergraduate student (Sarah) who explained to me her data analysis on the potency of different types of drugs on colorectal cancer. One of the MD students that I was working with showed me some of his work with pipetting tumor cells to be tested for what types of proteins are in them. He explained to me that they transfer tumor cells directly from the OR to the lab to create buffer solutions and test them for what proteins they have inside of them in order to assign different drugs to each solution to test which drug is most effective at dismantling the proteins existing in those solutions. This was particularly interesting especially after learning about buffer solutions in chemistry; seeing one of the MDs put my chemistry knowledge to use was spectacular. I actually got a feel for what I was learning out of a textbook– it was the tangible aspect of all the calculations that I did throughout this year. It’s so fascinating to me that the other side of what seems intangible, almost theoretical numbers are physical appliances with very visible applications. The other MD took me around the lab for a tour to show me its basic functions and the equipment used to conduct respective experiments. But they also explained to me that most of their research isn’t actual, tangible lab work. Rather, most of their time is spent analyzing the data that they collect evaluating cancer drugs and different mechanisms to approach cancer cures. Again, my chemistry and math knowledge was laid out on a practical level as I observed the MDs and the undergraduate (Sarah) calculate standard deviation when determining the potency of each drug; such practical application with data analysis reminded me a lot of pharmaceutical work, so it was interesting to draw a similarity between those two professions. In general, today was a pretty hands off day, but in the next few days, I’ll be observing drug effects on actual cancer patients that have come through the office, and I’ll be actually going into the clinic and meeting cancer patients with Dr. Hsu.